McCann et al., found different turmeric extracts could benefit the variants of SLC22A4 and IL-10 associated with IBD, by reducing inappropriate epithelial cell transport (SLC22A4, 503F) and increasing anti-inflammatory cytokine gene promoter activity (IL-10, -1082A) [33]. Here, SLC22A4 is linked to irritable bowel syndrome.